Bulevirtide (Hepcludex)

Status:
Red
Decision Date:
September 2022
 

Comments

RED: Treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA positive adults with compensated liver disease.

NHS England commissioned drug.  To be used in line with NHSE commissioning intentions.

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app